A Review of Recent Real-World Evidence Data in Metastatic Pancreatic Cancer
Comparison Between FOLFIRINOX and nal-IRI/FL as Second-line Treatment After Gemcitabine Plus Nab-paclitaxel for Pancreatic Cancer | Anticancer Research
O-1: NALIRIFOX versus nab-paclitaxel + gemcitabine in treatment-naive patients with mPDAC: additional results from NAPOLI 3 on Vimeo
Second-line and third-line therapy with nanoliposomal irinotecan (nal-IRI) in pancreatic cancer
Pankreaskarzinom: Palliative Systemtherapie
A schematic of encapsulation of irinotecan inside the liposome.... | Download Scientific Diagram
First-line liposomal irinotecan with oxaliplatin, 5-fluorouracil and leucovorin (NALIRIFOX) in pancreatic ductal adenocarcinoma: A phase I/II study - ScienceDirect
Transport pathway of irinotecan. Notes: A prodrug, irinotecan, is moved... | Download Scientific Diagram
Metastasiertes Pankreaskarzinom: Systemtherapie und molekulare Biomarker
Algorithmen zur Behandlung des Pankreaskarzinoms | Die Onkologie
MM-398 (nanoliposomal irinotecan): emergence of a novel therapy for the treatment of advanced pancreatic cancer | Future Oncology
Improved Efficacy and Reduced Toxicity Using a Custom-Designed Irinotecan-Delivering Silicasome for Orthotopic Colon Cancer | ACS Nano
Metastasiertes Pankreaskarzinom: Nab-Paclitaxel + Gemcitabin erweist sich als überlegen
Irinotecan: 25 years of cancer treatment - ScienceDirect
Liposomales Irinotecan plus 5-FU:LV zeigt deutliche Überlebensvorteile – Rosenfluh.ch
Spotlight on liposomal irinotecan for metastatic pancreatic cancer: pa | OTT
Cancers | Free Full-Text | Alternating Gemcitabine/Nab-Paclitaxel (GA) and 5-FU/Leucovorin/Irinotecan (FOLFIRI) as First-Line Treatment for De Novo Metastatic Pancreatic Cancer (MPC): Safety and Effect
Pharmacokinetic profile of nal-IRI and free irinotecan. A, plasma and... | Download Scientific Diagram
Metastatic Pancreatic Cancer: Current Treatment Options for Swiss Patients | Published in healthbook TIMES Oncology Hematology
Ein „unmet medical need“ – nur zögerliche Verbesserung der Outcomes - Onkologie - Universimed - Medizin im Fokus
Irinotecan verlängert Überleben beim fortgeschrittenen Pankreaskarzinom
Pankreaskarzinom: Irinotecan in Liposomen verdichtet
Molecules | Free Full-Text | Drug-Drug Interactions of Irinotecan, 5-Fluorouracil, Folinic Acid and Oxaliplatin and Its Activity in Colorectal Carcinoma Treatment
Nanoliposomal irinotecan plus fluorouracil and folinic acid as a second-line treatment option in patients with metastatic pancreatic ductal adenocarcinoma: a retrospective cohort study | BMC Cancer | Full Text
Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial - The Lancet
Population pharmacokinetics of liposomal irinotecan in patients with cancer and exposure–safety analyses in patients with metastatic pancreatic cancer - Brendel - 2021 - CPT: Pharmacometrics & Systems Pharmacology - Wiley Online Library
Improved Efficacy and Reduced Toxicity Using a Custom-Designed Irinotecan-Delivering Silicasome for Orthotopic Colon Cancer | ACS Nano
